Celldex Therapeutics, Inc. (CLDX) ownership: Top institutional holder: WELLINGTON MANAGEMENT GROUP LLP ($271.54M). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 8560476.00 | $271.54M | 2026-03-31 |
| Kynam Capital Management, LP | 5840567.00 | $185.26M | 2026-03-31 |
| BlackRock, Inc. | 5369885.00 | $170.33M | 2026-03-31 |
| FMR LLC | 3749048.00 | $118.92M | 2026-03-31 |
| VANGUARD GROUP INC | 4027407.00 | $109.38M | 2025-12-31 |
| Point72 Asset Management, L.P. | 3229939.00 | $102.45M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2960895.00 | $93.92M | 2026-03-31 |
| STATE STREET CORP | 2804168.00 | $88.95M | 2026-03-31 |
Back to CLDX overview · CLDX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.